|
|
||||||||
1 Department of Neuroscience & Center for Neurovirology, Temple University School of Medicine, 1900 N 12th Street (015-96), Philadelphia, PA 19122, USA
2 Laboratory of Biology, Don C. Gnocchi Foundation, IRCCS, 20148 Milan, Italy
3 Department of Biology, Temple University School of Medicine, 1900 N 12th Street (015-96), Philadelphia, PA 19122, USA
Correspondence
Bassel E. Sawaya
sawaya{at}temple.edu
Previous examination of the effect of TCF-4 on transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in human astrocytic cells found that TCF-4 affects the HIV-1 promoter through the GC-rich domain (nt 80 to nt 68). Here, the physical interaction and a functional consequence of TCF4Sp1 contact were characterized. It was shown that expression of TCF-4 in U-87 MG (human astrocytic) cells decreased basal and Sp1-mediated transcription of the HIV-1 promoter. Results from a GST pull-down assay, as well as combined immunoprecipitation and Western blot analysis of protein extracts from U-87 MG cells, revealed an interaction of Sp1 with TCF-4. Using in vitro protein chromatography, the region of Sp1 that contacts TCF-4 was mapped to aa 266350. It was also found that, in cell-free extracts, TCF-4 prevented dsDNA-dependent protein kinase (DNA-PK)-mediated Sp1 phosphorylation. Surprisingly, TCF-4 failed to decrease Sp1-mediated transcription of the HIV-1 long terminal repeat (LTR) and Sp1 phosphorylation in cells expressing HIV-1 Tat. Results from immunoprecipitation/Western blotting demonstrated that TCF-4 lost its ability to interact with Sp1, but not with Tat, in Tat-transfected cells. Taken together, these findings suggest that activity at the HIV-1 promoter is influenced by phosphorylation of Sp1, which is affected by Tat and DNA-PK. Interactions among TCF-4, Sp1 and/or Tat may determine the level of viral gene transcription in human astrocytic cells.
This article has been cited by other articles:
![]() |
A. Kumar, A. Zloza, R. T. Moon, J. Watts, A. R. Tenorio, and L. Al-Harthi Active {beta}-Catenin Signaling Is an Inhibitory Pathway for Human Immunodeficiency Virus Replication in Peripheral Blood Mononuclear Cells J. Virol., March 15, 2008; 82(6): 2813 - 2820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Carroll-Anzinger, A. Kumar, V. Adarichev, F. Kashanchi, and L. Al-Harthi Human Immunodeficiency Virus-Restricted Replication in Astrocytes and the Ability of Gamma Interferon To Modulate This Restriction Are Regulated by a Downstream Effector of the Wnt Signaling Pathway J. Virol., June 1, 2007; 81(11): 5864 - 5871. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mameli, S. L. Deshmane, M. Ghafouri, J. Cui, K. Simbiri, K. Khalili, R. Mukerjee, A. Dolei, S. Amini, and B. E. Sawaya C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9 J. Gen. Virol., February 1, 2007; 88(2): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |